Document is current
Any future updates will be listed below
-
Authors
Adair, Dionne
Bagheri, AmirBehzad
Yosef, Matheos
Khalatbari, Shokoufeh
Lewis, Toby
Mohan, Arjun https://orcid.org/0000-0002-6190-7592
Lugogo, Njira
- License Information
-
More Information
Article History
Received: 7 July 2024
Accepted: 21 November 2024
First Online: 23 December 2024
Declarations
:
: Dionne Adair, AmirBehzad Bagheri, Matheos Yosef, Shokoufeh Khalatbari, and Toby Lewis have nothing to disclose. Arjun Mohan has received consulting fees from Verona Pharm LLC. Njira Lugogo is an Editorial Board member of Pulmonary Therapy. Njira Lugogo was not involved in the selection of peer reviewers for the manuscript nor in any of the subsequent editorial decisions. Njira Lugogo received consulting fees from Amgen, AstraZeneca, Avillion, Genentech, GSK, Nioxx, Novartis, Regeneron, Sanofi, and Teva; honoraria for non-speakers bureau presentations from GSK, TEVA and Astra Zeneca; and travel support from Astra Zeneca, SANOFI, TEVA, Regeneron and GSK; her institution received research support from Amgen, AstraZeneca, Avillion, Bellus, Evidera, Gossamer Bio, Genentech, GSK, Janssen, Regeneron, Sanofi, Novartis and Teva. She is an honorary faculty member of Observational and Pragmatic Research Institute (OPRI) but does not receive compensation for this role.
: The data used was non-identifiable. The database is publicly available. The Coronary Artery Risk Development in Young Adults (CARDIA) study is registered on ClinicalTrials.gov with the identifier NCT00005130.
